Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
Total Valuation
Chugai Pharmaceutical Co has a market cap or net worth of $97.28B. The enterprise value is $15.04T.
Market Cap$97.28B
Enterprise Value$15.04T
Share Statistics
Chugai Pharmaceutical Co has 1,679,057,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,679,057,600
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Chugai Pharmaceutical Co’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 20.83%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)20.83%
Return on Capital Employed (ROCE)0.29
Revenue Per Employee250.29M
Profits Per Employee86.35M
Employee Count5,026
Asset Turnover0.51
Inventory Turnover1.31
Valuation Ratios
The current PE Ratio of Chugai Pharmaceutical Co is 33.2. Chugai Pharmaceutical Co’s PEG ratio is 2.60.
PE Ratio33.2
PS Ratio10.78
PB Ratio6.70
Price to Fair Value6.70
Price to FCF43.31
Price to Operating Cash Flow40.56
PEG Ratio2.60
Income Statement
In the last 12 months, Chugai Pharmaceutical Co had revenue of 1.26T and earned 434.01B in profits. Earnings per share was 263.73.
Revenue1.26T
Gross Profit894.25B
Operating Income590.19B
Pretax Income597.81B
Net Income434.01B
EBITDA631.37B
Earnings Per Share (EPS)263.73
Cash Flow
In the last 12 months, operating cash flow was 389.45B and capital expenditures -76.27B, giving a free cash flow of 313.18B billion.
Operating Cash Flow389.45B
Free Cash Flow313.18B
Free Cash Flow per Share186.52
Dividends & Yields
Chugai Pharmaceutical Co pays an annual dividend of $0.792, resulting in a dividend yield of 2.38%
Dividend Per Share$0.792
Dividend Yield2.38%
Payout Ratio77.63%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change34.88%
50-Day Moving Average54.89
200-Day Moving Average49.49
Relative Strength Index (RSI)60.90
Average Volume (3m)3.09K
Important Dates
Chugai Pharmaceutical Co upcoming earnings date is Apr 24, 2026, Before Open (Confirmed).
Last Earnings DateJan 29, 2026
Next Earnings DateApr 24, 2026
Ex-Dividend Date―
Financial Position
Chugai Pharmaceutical Co as a current ratio of 4.23, with Debt / Equity ratio of 0.00%
Current Ratio4.23
Quick Ratio3.56
Debt to Market Cap0.00
Net Debt to EBITDA-0.68
Interest Coverage Ratio575.24
Taxes
In the past 12 months, Chugai Pharmaceutical Co has paid 163.79B in taxes.
Income Tax163.79B
Effective Tax Rate0.27
Enterprise Valuation
Chugai Pharmaceutical Co EV to EBITDA ratio is 20.81, with an EV/FCF ratio of 41.95.
EV to Sales10.44
EV to EBITDA20.81
EV to Free Cash Flow41.95
EV to Operating Cash Flow33.74
Balance Sheet
Chugai Pharmaceutical Co has $979.70B in cash and marketable securities with $0.00 in debt, giving a net cash position of $979.70B billion.
Cash & Marketable Securities$979.70B
Total Debt$0.00
Net Cash$979.70B
Net Cash Per Share$583.48
Tangible Book Value Per Share$1.20K
Margins
Gross margin is 71.09%, with operating margin of 46.92%, and net profit margin of 34.50%.
Gross Margin71.09%
Operating Margin46.92%
Pretax Margin47.52%
Net Profit Margin34.50%
EBITDA Margin50.19%
EBIT Margin47.60%
Analyst Forecast
The average price target for Chugai Pharmaceutical Co is $67.30, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$67.30
Price Target Upside12.67% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast―